Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells.
Koya T, Yoshida K, Togi M, Niida Y, Togi S, Ura H, Mizuta S, Kato T Jr, Yamada S, Shibata T, Liu YC, Yuan SS, Wu DC, Kobayashi H, Utsugisawa T, Kanno H, Shimodaira S.
Koya T, et al. Among authors: ura h.
Cancers (Basel). 2023 Jul 14;15(14):3627. doi: 10.3390/cancers15143627.
Cancers (Basel). 2023.
PMID: 37509288
Free PMC article.